Characteristics of Lung Cancers Harboring <i>NRAS</i> Mutations

Abstract

NRAS mutations define a distinct subset of lung cancers (∼1%) with potential sensitivity to MEK inhibitors. Although NRAS mutations are more common in current/former smokers, the types of mutations are not those classically associated with smoking.